TOPGEN
Shanghai, Shanghai, China
About TOPGEN
TOPGEN is committed to tumor precision medical products and engages in precision medicine. Continuous industry research and development, as well as the construction of an industry ecology, will protect human health. It adheres to international norms, standards, and industry guidelines, as well as introduces and develops international advanced technologies and testing methods. It serves large tertiary hospitals, specialized hospitals, general hospitals, research institutions, and pharmaceutical companies in China.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 251 – 500
- Estimated revenue: $50K – $100K
- Total funding: $36.9M
- Funding stage: IPO
- Last round: Series D (Jun 2022)
- Ticker: neeq:836219
- Website: topgen.com.cn
- Phone: 021-5080 0383
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/topgen-2246789 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.